The role of BLyS/BLyS receptors in anti-chromatin B cell regulation

International Immunology

Volumn 19, Issue 4, 2007, Pages 465-475

  Hondowicz, Brian D ^a   Alexander, Shawn T ^a   Quinn, William J ^b   Pagán, Antonio J ^a   Metzgar, Michele H ^a   Cancro, Michael P ^b   Erikson, Jan ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE ANTIGEN; B LYMPHOCYTE RECEPTOR; B LYMPHOCYTE STIMULATOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR INTRINSIC ACTIVITY; SPLEEN; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIBODY FORMATION; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-CELL MATURATION ANTIGEN; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN KAPPA-CHAINS; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, CHEMOKINE; RECEPTORS, TUMOR NECROSIS FACTOR; SPLEEN; T-LYMPHOCYTES, HELPER-INDUCER; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN;

EID: 34047134533     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm011     Document Type: Article

References (76)

1. Mackay, F., Schneider, P., Rennert, P. and Browning, J. 2003. BAFF and APRIL: A tutorial on B cell survival. Annu. Rev. Immunol. 21:231.
2. Medema, J. P., Planelles-Carazo, L., Hardenberg, G. and Hahne, M. 2003. The uncertain glory of APRIL. Cell Death Differ. 10:1121.
3. Kalled, S. L. 2005. The role of BAFF in immune function and implications for autoimmunity. Immunol. Rev. 204:43.
4. Dillon, S. R., Gross, J. A., Ansell, S. M. and Novak, A. J. 2006. An APRIL to remember: Novel TNF ligands as therapeutic targets. Nat. Rev. Drug Discov. 5:235.
5. Hsu, B. L., Harless, S. M., Lindsley, R. C., Hilbert, D. M. and Cancro, M. P. 2002. Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators. J. Immunol. 168:5993.
6. O'Connor, B. P., Raman, V. S., Erickson, L. D. et al. 2004. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199:91.
7. Avery, D. T., Kalled, S. L., Ellyard, J. I. et al. 2003. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J. Clin. Invest. 112:286.
8. Allman, D., Lindsley, R. C., DeMuth, W., Rudd, K., Shinton, S. A. and Hardy, R. R. 2001. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 167:6834.
9. Miller, D. J. and Hayes, C. E. 1991. Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ mice. Eur. J. Immunol. 21:1123.
10. Lentz, V. M., Hayes, C. E. and Cancro, M. P. 1998. Bcmd decreases the life span of B-2 but not B-1 cells in A/WySnJ mice. J. Immunol. 160:3743.
11. Schiemann, B., Gommerman, J. L., Vora, K. et al. 2001. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293:2111.
12. Thompson, J. S., Bixler, S. A., Qian, F. et al. 2001. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293:2108.
13. Shulga-Morskaya, S., Dobles, M., Walsh, M. E. et al. 2004. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J. Immunol. 173:2331.
14. Yan, M., Wang, H., Chan, B. et al. 2001. Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol. 2:638.
15. von Bulow, G. U., van Deursen, J. M. and Bram, R. J. 2001. Regulation of the T-independent humoral response by TACI. Immunity 14:573.
16. Seshasayee, D., Valdez, P., Yan, M., Dixit, V. M., Tumas, D. and Grewal, I. S. 2003. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18:279.
17. Salzer, U., Chapel, H. M., Webster, A. D. et al. 2005. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat. Genet. 37:820.
18. Castigli, E., Wilson, S. A., Garibyan, L. et al. 2005. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat. Genet. 37:829.
19. Zhang, J., Roschke, V., Baker, K. P. et al. 2001. Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus. J. Immunol. 166:6.
20. Cheema, G. S., Roschke, V., Hilbert, D. M. and Stohl, W. 2001. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 44:1313.
21. Groom, J., Kalled, S. L., Cutler, A. H. et al. 2002. Association of BAFF/ BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J. Clin. Invest. 109:59.
22. Mariette, X., Roux, S., Zhang, J. et al. 2003. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann. Rheum. Dis. 62:168.
23. Stohl, W., Metyas, S., Tan, S. M. et al. 2003. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum. 48:3475.
24. Carter, R. H., Zhao, H., Liu, X. et al. 2005. Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus. Arthritis Rheum. 52:3943.
25. Mackay, F., Woodcock, S. A., Lawton, P. et al. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190:1697.
26. Moore, P. A., Belvedere, O., Orr, A. et al. 1999. BLyS: Member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285:260.
27. Gross, J. A., Johnston, J., Mudri, S. et al. 2000. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404:995.
28. Khare, S. D., Sarosi, I., Xia, X. Z. et al. 2000. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl Acad. Sci. USA 97:3370.
29. Lesley, R., Xu, Y., Kalled, S. L. et al. 2004. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 20:441.
30. Thien, M., Phan, T. G., Gardam, S. et al. 2004. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20:785.
31. Schmidt, K. N., Hsu, C. W., Griffin, C. T., Goodnow, C. C. and Cyster, J. G. 1998. Spontaneous follicular exclusion of SHP1-deficient B cells is conditional on the presence of competitor wild-type B cells. J. Exp. Med. 187:929.
32. Seo, S., Mandik-Nayak, L. and Erikson, J. 2003. B cell anergy and systemic lupus erythematosus. Curr. Dir. Autoimmun. 6:1.
33. Fields, M. L. and Erikson, J. 2003. The regulation of lupus-associated autoantibodies: Immunoglobulin transgenic models. Curr. Opin. Immunol. 15:709.
34. Radic, M. Z., Mascelli, M. A., Erikson, J., Shan, H. and Weigert, M. 1991. Ig H and L chain contributions to autoimmune specificities. J. Immunol. 146:176.
35. Shlomchik, M., Mascelli, M., Shan, H. et al. 1990. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J. Exp. Med. 171:265.
36. Roark, J. H., Kuntz, C. L., Nguyen, K.-A., Caton, A. J. and Erikson, J. 1995. Breakdown of B cell tolerance in a mouse model of SLE. J. Exp. Med. 181:1157.
37. Mandik-Nayak, L., Bui, A., Noorchashm, H., Eaton, A. and Erikson, J. 1997. Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: Localization to the T-B interface of the splenic follicle. J. Exp. Med. 186:1257.
38. Mandik-Nayak, L., Seo, S. J., Sokol, C., Potts, K. M., Bui, A. and Erikson, J. 1999. MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J. Exp. Med. 189:1799.
39. Seo, S. J., Fields, M. L., Buckler, J. L., Reed, A. J. et al. 2002. The impact of T helper and T regulatory cells on the regulation of antidouble-stranded DNA B cells. Immunity 16:535.
40. Fields, M. L., Hondowicz, B. D., Wharton, G. N. et al. 2005. The regulation and activation of lupus-associated B cells. Immunol. Rev. 204:165.
41. Mandik-Nayak, L., Seo, S. J., Eaton-Bassiri, A., Allman, D., Hardy, R. R. and Erikson, J. 2000. Functional consequences of the developmental arrest and follicular exclusion of anti-doublestranded DNA B cells. J. Immunol. 164:1161.
42. Mandik-Nayak, L., Nayak, S., Sokol, C. et al. 2000. The origin of anti-nuclear antibodies in bcl-2 transgenic mice. Int. Immunol. 12:353.
43. Hardy, R. R., Carmack, C. E., Shinton, S. A., Kemp, J. D. and Hayakawa, K. 1991. Resolution and characterization of pro-B and pre-B cell stages in normal mouse bone marrow. J. Exp. Med 173:1213.
44. Fields, M. L., Hondowicz, B. D., Metzgar, M. H. et al. 2005. CD4+CD25+ regulatory T cells inhibit the maturation but not the initiation of an autoantibody response. J. Immunol. 175:4255.
45. Fields, M. L., Hondowicz, B. D., Wharton, G. N. et al. 2005. The regulation and activation of lupus-associated B cells. Immunol. Rev. 204:165.
46. Roark, J. H., Bui, A., Nguyen, K. A., Mandik, L. and Erikson, J. 1997. Persistence of functionally compromised anti-dsDNA B cells in the periphery of non-autoimmune mice. Int. Immunol. 9:1615.
47. Prak, E. L., Trounstine, M., Huszar, D. and Weigert, M. 1994. Light chain editing in k-deficient animals: A potential mechanism of B cell tolerance. J. Exp. Med. 180:1805.
48. Schmidt, K. N. and Cyster, J. G. 1999. Follicular exclusion and rapid elimination of hen egg lysozyme autoantigen-binding B cells are dependent on competitor B cells, but not on T cells. J. Immunol. 162:284.
49. Pevzner, V., Wolf, I., Burgstahler, R., Forster, R. and Lipp, M. 1999. Regulation of expression of chemokine receptor BLR1/CXCR5 during B cell maturation. Curr. Top. Microbiol. Immunol. 246:79.
50. Cyster, J. G., Ansel, K. M., Reif, K. et al. 2000. Follicular stromal cells and lymphocyte homing to follicles. Immunol. Rev. 176:181.
51. Chan, E. Y.T. and MacLennan, I. C.M. 1993. Only a small proportion of splenic B cells in adults are short-lived virgin cells. Eur. J. Immunol. 23:357.
52. Okada, T., Miller, M. J., Parker, I. et al. 2005. Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol. 3:e150.
53. Reif, K., Ekland, E. H., Ohl, L. et al. 2002. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 416:94.
54. Smith, S. H. and Cancro, M. P. 2003. Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors. J. Immunol. 170:5820.
55. Ng, L. G., Sutherland, A. P., Newton, R. et al. 2004. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J. Immunol. 173:807.
56. Srivastava, B., Quinn, W. J. III, Hazard, K., Erikson, J. and Allman, D. 2005. Characterization of marginal zone B cell precursors. J. Exp. Med. 202:1225.
57. Crowley, J. E., Treml, L. S., Stadanlick, J. E., Carpenter, E. and Cancro, M. P. 2005. Homeostatic niche specification among naive and activated B cells: A growing role for the BLyS family of receptors and ligands. Semin. Immunol. 17:193.
58. Fields, M. L., Nish, S. A., Hondowicz, B. D. et al. 2005. The influence of effector T cells and Fas ligand on lupus-associated B cells. J. Immunol. 175:104.
59. Fields, M. L., Sokol, C. L., Eaton-Bassiri, A., Seo, S. J., Madaio, M. P. and Erikson, J. 2001. Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells. J. Immunol. 167:2370.
60. Tan, E. M. 1989. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44:93.
61. Schneider, P., MacKay, F., Steiner, V. et al. 1999. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189:1747.
62. Roschke, V., Sosnovtseva, S., Ward, C. D. et al. 2002. BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases. J. Immunol. 169:4314.
63. Mackay, F. and Browning, J. L. 2002. BAFF: A fundamental survival factor for B cells. Nat. Rev. Immunol. 2:465.
64. Pers, J. O., Daridon, C., Devauchelle, V. et al. 2005. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann. N. Y. Acad. Sci. 1050:34.
65. Batten, M., Groom, J., Cachero, T. G. et al. 2000. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192:1453.
66. Rolink, A. G., Tschopp, J., Schneider, P. and Melchers, F. 2002. BAFF is a survival and maturation factor for mouse B cells. Eur. J. Immunol. 32:2004.
67. Bolland, S. and Ravetch, J. V. 2000. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13:277.
68. Bygrave, A. E., Rose, K. L., Cortes-Hernandez, J. et al. 2004. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2:E243.
69. Fukuyama, H., Nimmerjahn, F. and Ravetch, J. V. 2005. The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells. Nat. Immunol. 6:99.
70. Lang, J., Arnold, B., Hammerling, G. et al. 1997. Enforced bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J. Exp. Med. 186:1513.
71. Fang, W., Weintraub, B. C., Dunlap, B. et al. 1998. Self-reactive B lymphocytes overexpressing Bcl-xL escape negative selection and are tolerized by clonal anergy and receptor editing. Immunity 9:35.
72. Cancro, M. P. 2004. Peripheral B-cell maturation: The intersection of selection and homeostasis. Immunol. Rev. 197:89.
73. Rui, L., Vinuesa, C. G., Blasioli, J. and Goodnow, C. C. 2003. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nat. Immunol. 4:594.
74. Rui, L., Healy, J. I., Blasioli, J. and Goodnow, C. C. 2006. ERK signaling is a molecular switch integrating opposing inputs from B cell receptor and T cell cytokines to control TLR4-driven plasma cell differentiation. J. Immunol. 177:5337.
75. Cancro, M. P. 2004. The BLyS family of ligands and receptors: An archetype for niche-specific homeostatic regulation. Immunol. Rev. 202:237.
76. Treml, L. S., Crowley, J. E. and Cancro, M. P. 2006. BLyS receptor signatures resolve homeostatically independent compartments among naive and antigen-experienced B cells. Semin. Immunol. 18:297.